AI
WST icon

Atria Investments’s West Pharmaceutical WST Stock Holding History

Atria Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
9,238
+2,368
+34% +$724K 0.03% 528
2026
Q1 		$1.72M Sell
6,870
-374
-5% -$93.1K 0.02% 776
2025
Q4 		$1.99M Sell
7,244
-412
-5% -$113K 0.02% 719
2025
Q3 		$2.01M Buy
7,656
+887
+13% +$216K 0.02% 718
2025
Q2 		$1.48M Sell
6,769
-471
-7% -$101K 0.02% 856
2025
Q1 		$1.62M Sell
7,240
-1,428
-16% -$394K 0.02% 788
2024
Q4 		$2.84M Sell
8,668
-406
-4% -$128K 0.04% 548
2024
Q3 		$2.72M Buy
9,074
+1,475
+19% +$452K 0.03% 567
2024
Q2 		$2.5M Sell
7,599
-436
-5% -$154K 0.03% 569
2024
Q1 		$3.18M Sell
8,035
-617
-7% -$228K 0.04% 485
2023
Q4 		$3.05M Sell
8,652
-1,119
-11% -$396K 0.05% 442
2023
Q3 		$3.67M Buy
9,771
+338
+4% +$131K 0.07% 361
2023
Q2 		$3.61M Buy
9,433
+157
+2% +$56.1K 0.07% 358
2023
Q1 		$3.21M Buy
9,276
+669
+8% +$195K 0.06% 374
2022
Q4 		$2.03M Buy
8,607
+2,589
+43% +$614K 0.04% 505
2022
Q3 		$1.48M Sell
6,018
-913
-13% -$278K 0.03% 584
2022
Q2 		$2.1M Sell
6,931
-7,271
-51% -$2.37M 0.04% 493
2022
Q1 		$5.83M Buy
14,202
+421
+3% +$165K 0.1% 234
2021
Q4 		$6.46M Buy
13,781
+1,154
+9% +$497K 0.12% 215
2021
Q3 		$5.36M Buy
12,627
+1,835
+17% +$774K 0.1% 230
2021
Q2 		$3.88M Sell
10,792
-493
-4% -$163K 0.07% 300
2021
Q1 		$3.18M Buy
11,285
+6,415
+132% +$1.84M 0.07% 322
2020
Q4 		$1.38M Sell
4,870
-14,912
-75% -$4.18M 0.03% 550
2020
Q3 		$5.44M Buy
+19,782
New +$5.24M 0.17% 144
2020
Q1 		– Sell
-3,763
Closed -$566K – 1209
2019
Q4 		$566K Buy
3,763
+489
+15% +$71.2K 0.02% 735
2019
Q3 		$464K Buy
+3,274
New +$451K 0.02% 605

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Atria Investments's WST Position: Q2 2026 in Review

Atria Investments increased its West Pharmaceutical (WST) stake by 34% in Q2 2026, buying an estimated $724K and bringing the position to 9,238 shares worth $3.32M. The position accounts for 0.03% of the portfolio, ranked #528.

Atria Investments first reported a position in WST in Q3 2019 and has held it in 26 quarters since. The position peaked at $6.46M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Atria Investments held 9,238 shares of West Pharmaceutical worth $3.32M as of Q2 2026.
  • Atria Investments bought 2,368 West Pharmaceutical shares in Q2 2026, an estimated $724K.
  • West Pharmaceutical made up 0.03% of Atria Investments's portfolio in Q2 2026, its #528 holding.
  • Atria Investments first reported a position in West Pharmaceutical in Q3 2019 and has held it in 26 quarters since.
  • Atria Investments's West Pharmaceutical position peaked at $6.46M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.